bioAffinity Technologies, Inc. 8-K Filing: Key Insights & Stock Info

Based on the provided section of the financial report, here are the key insights and information extracted:

1. Entity Information:

• Company Name: bioAffinity Technologies, Inc.
• CIK: 0001712762
• SEC File Number: 001-41463
• EIN: 46-5211056
• Address: 3300 Nacogdoches Road Suite 216, San Antonio, TX 78217
• Contact: (210) 698-5334

2. Report Type:

• The document is an 8-K filing, which is typically used to report significant events that shareholders should know about.

3. Report Date:

• Date of Filing: December 20, 2024
• The report covers a specific date: December 20, 2024.

4. Stock Information:

• Common Stock:
• • Par Value: $0.007 per share.
• Warrants:
• • The report includes information regarding warrants to purchase common stock.

5. Stock Exchange Listings:

• Common Stock is listed on NASDAQ under the ticker symbol BIAF.
• Warrants are listed on NASDAQ under the ticker symbol BIAFW.

6. Units of Measure:

• The financial information is presented in USD (United States Dollars) and in shares.

7. Key Financial Segments:

• The report includes classifications for:
• • Common Stock: Identified as a segment with a par value of $0.007.
  • Warrants to Purchase Common Stock: Identified as a separate financial segment.

8. Document Structure:

• The report uses XBRL (eXtensible Business Reporting Language) for structured financial data, which is common in SEC filings to facilitate better data analysis and reporting.

Summary:

This section of the financial report provides essential information about bioAffinity Technologies, Inc., including its stock details, filing type, and pertinent identifiers. The focus on common stock and warrants suggests that the company may be involved in financing activities or other significant corporate actions that could impact shareholders.